4//SEC Filing
Huttner Kenneth 4
Accession 0001209191-20-009448
CIK 0001664106other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 8:00 PM ET
Size
5.2 KB
Accession
0001209191-20-009448
Insider Transaction Report
Form 4
Huttner Kenneth
SVP, Head of Clinical Dev.
Transactions
- Award
Stock Option (right to buy)
2020-02-11+50,000→ 50,000 totalExercise: $7.11Exp: 2030-02-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% vests on 01/01/2021 and the remainder vests in equal monthly installments over the next 36 months.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001768318
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 8:00 PM ET
- Size
- 5.2 KB